Cardiovascular Systems Reports Fiscal 2016 Fourth-Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks rally, crude prices fall
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
Needham & Company Raises Price Target on Cardiovascular Systems (CSII) to $27 Following 4Q Beat
August 4, 2016 8:14 AM EDTNeedham & Company reiterated a Buy rating on Cardiovascular Systems (NASDAQ: CSII), and raised the price target to $27.00 (from $23.00), following the company's 4Q earnings report. Revenue was $48.5M vs. consensus of $46.0M and GAAP EPS was ($0.15) vs. consensus of ($0.20).
Analyst Mike Matson... More
BofA/Merrill Lynch Upgrades Cardiovascular Systems (CSII) to Neutral
August 4, 2016 6:51 AM EDTBofA/Merrill Lynch upgraded Cardiovascular Systems (NASDAQ: CSII) from Underperform to Neutral.
For an analyst ratings summary and ratings history on Cardiovascular Systems click here. For more ratings news on Cardiovascular Systems click here.
Shares of Cardiovascular Systems closed at $19.74 yesterday.
... MoreCardiovascular Systems (CSII) Tops Q4 EPS by 5c; Offers Q1 Outlook
August 3, 2016 4:41 PM EDTCardiovascular Systems (NASDAQ: CSII) reported Q4 EPS of ($0.15), $0.05 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $48.5 million versus the consensus estimate of $46.01 million.
GUIDANCE:
Cardiovascular Systems sees Q1 2017 EPS of ($0.21)-($0.18). Cardiovascular Systems sees Q1 2017... More
